Antiviral susceptibility of herpes simplex viruses and its clinical correlates: A single center’s experience

N. Rabella, M. Otegui, R. Labeaga, P. Rodríguez, N. Margall, M. Gurguí, G. Prats

Research output: Contribution to journalArticleResearchpeer-review

6 Citations (Scopus)

Abstract

The in vitro susceptibility to acyclovir of 204 herpes simplex virus isolates from 165 immunocompromised patients treated at our hospital was determined by the cytopathic effect reduction assay. Approximately 95% of herpes simplex virus 1 and 73% of herpes simplex virus 2 isolates were inhibited by acyclovir at concentrations of <2 μg/mL. From 8 patients (5%), an isolate with low susceptibility to acyclovir (50% inhibitory dose, >3 μg/mL) was recovered. Medical records of 83 patients were reviewed. Lesions resolved in most of the patients, independent of treatment. Treatment failures were not always associated with isolation of an in vitro-resistant virus. On the contrary, when a virus with low susceptibility to acyclovir was isolated, resolution of the lesion was the rule. In 9 of 10 patients with subsequent recurrent episodes of disease, the susceptibility of the viruses isolated was similar to that of the first episode. Routine susceptibility testing in our geographic area is not encouraged because of the low incidence of acyclovir-resistant herpes simplex viruses.
Original languageEnglish
Pages (from-to)1055-1060
JournalClinical Infectious Diseases
Volume34
DOIs
Publication statusPublished - 15 Apr 2002

Fingerprint Dive into the research topics of 'Antiviral susceptibility of herpes simplex viruses and its clinical correlates: A single center’s experience'. Together they form a unique fingerprint.

Cite this